Exploristics Clinical Data Analysis and Modelling

At Exploristics we provide innovative analysis solutions to maximise the information derived from your clinical data. We offer a unique expertise in the exploratory analysis and clinical application of biomarkers, pharmacogenomics, imaging and observational data.

The team at Exploristics offers more than a statistical analysis and reporting service. We take pride in using our analytical skills and scientific expertise to help you make informed decisions. We work closely with our customers to understand their data analysis needs and to provide practical solutions. So far, we have worked successfully with pharmaceutical, biotechnology, medical diagnostics and devices companies as well as healthcare providers. Our service is friendly and cost-effective and our work is compliant with GCP / ICH guidelines.

Clinical data exploration, mining and modelling

Our broad experience using multiple analysis techniques enables us to perform a wide range of exploratory data analyses. These allow us to gain a thorough understanding of the data and to detect meaningful patterns in the data.

Furthermore, we can develop mathematical models that describe complex processes and then study the behaviour of those models under different conditions. This approach can save time and money by allowing you to evaluate your options by running virtual experiments. These methods are useful for solving complex problems that involve numerous factors, such as the design of complex studies.

Clinical application of biomarkers and pharmacogenomics data

We are experts in the clinical application of biomarkers and pharmacogenomics (PGx). We help you integrate these data into clinical development, evaluate your portfolio to find opportunities for these data, design experiments, analyse data and provide information on how to use the results. We also work with you to enable the integration of these data into your research programs.

Other clinical data analysis support

We also provide analysis support for the following study types and activities: epidemiology; pre-clinical studies; translational medicine; experimental medicine; medical devices; pharmacovigilance; in-licensing support; and training, education and consultancy.

Biomarker data management, visualisation and analysis tools

Exploristics has partnered with OmicSoft Corporation to supply and distribute biomarker data management, visualisation and analysis tools in Europe. OmicSoft has designed software that is easy to use for the bench scientists, but powerful enough to be used by the bioinformatician or statistician. Exploristics offers two software packages: Array Studio and Array Server.

Statistics and visualisation for biomarker data analysis

Array Studio provides state-of-the-art statistics and visualisation for the analysis of high dimensional data. Array Studio supports all popular microarray platforms (Affymetrix, Agilent, Illumina, etc.), as well as SNP / genotype platforms (Affymetrix, Illumina, etc.) and CNV platforms (Affymetrix, Illumina and Agilent). Array Studio provides a full workflow for importing and normalisation of data, quality control, analysis, and clustering and pattern analysis.

Microarray / SNP / copy number variation (CNV) project integration

Array Server is an enterprise solution, allowing users to store, share, search and integrate their microarray / SNP / CNV projects. Array Server supports any number of high dimensional platforms, including the same platforms supported by Array Studio. Users can search by meta data, use search-by-gene functions, and can even profile gene regions across multiple studies.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

ARTES Enters into a Partnership with Henkel for a Three-Year Research Programme

ARTES Biotechnology has announced its collaboration with Henkel in a joint three-year research programme that is granted by the German national BMBF (German Ministery of Education and Research) within the CLIB2021 cluster (Wettbewerb Industrielle Biotechnologie 2021). The cooperation aims to adva

White Papers

Management and Analysis of Biomarker Data

Management and Analysis of Biomarker Data

Exploristics Ltd

Exploristics Images

Products and Services


Press Release

8 March 2011

Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a leading provider of contract manufacturing and development services for the biopharmaceut

Read more
10 May 2009

ARTES Biotechnology has announced its collaboration with Henkel in a joint three-year research programme that is granted by the German national BMBF (German Ministery of Education and Research) within the CLIB2021 cluster (Wettbewerb Industrielle Biotechnologie 2021). The cooperation aims to adva

Read more
14 January 2008

ARTES Biotechnology, which specializes in recombinant protein production from yeast expression systems, and Rhein Minapharm Biogenetics, a subsidiary of Minapharm, jointly announced the start of a strategic collaboration to develop three therapeutic proteins. Financial details were not disclosed.

Read more
8 October 2007

ARTES Biotechnology GmbH expands technology platform Having achieved notable success with the Hansenula technology for years, the biotech company ARTES has now concluded an exclusive partnership with the internationally renowned Leibniz Institute of Plant Genetics and Crop Plant

Read more
17 July 2007

"We are looking forward to working with an international team“, says Dr Melanie Dröttboom, head of business development of Artes Biotechnology GmbH. Biotech company Artes, based near Düsseldorf, has been confirmed that it is developing an aptamer-based microarray for

Read more
29 May 2007

ACE Pharmaceuticals today announced that the first patient has entered the Phase III trial also known as the Levamisole trial. This trial was accepted by the EMEA by November 2006. The goal of this trial, which was accepted by the EMEA in November 2006, is to assess the efficacy and sa

Read more
9 January 2007

ARTES announces the grant of the European patent on increasing recombinant protein secretion in yeast by co-expression of Calnexin, a protein responsible in intracellular quality control and sorting. In extensive studies, ARTES could show that overexpression of Calnexin results in sign

Read more
19 June 2006

Kiel - Erkrath, June 19, 2006. PROTEO Biotech AG, a wholly owned subsidiary of PROTEO Inc., USA, has signed a cooperation agreement with ARTES Biotechnology GmbH. The aim of the agreement is the marketing of Elafin, the lead product of PROTEO Biotech AG / PROTEO Inc., in India, Egypt and Argentin

Read more

Regional Offices

Exploristics Ltd

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.